BACKGROUND: To investigate the effect of helminth infections and their treatment during pregnancy on HIV load, we conducted a 2 × 2 factorial randomized controlled trial of albendazole versus placebo and praziquantel versus placebo in pregnant women in Entebbe, Uganda. METHODS: Two hundred sixty-four HIV-infected pregnant women from the Entebbe Mother and Baby Study (ISRCTN 32849447) were included in this analysis. Women were tested for helminth infections at enrollment, and mean HIV load was compared between infected and uninfected groups. The effect of anthelmintic treatment on HIV load was evaluated at 6 weeks after treatment and at delivery using linear regression and adjusting for enrollment viral load. RESULTS: Hookworm and Trichuris infections were associated with higher mean viral load at enrollment [adjusted mean difference 0.24 log10 copies/mL, 95% confidence interval (CI): 0.01 to 0.47, P = 0.03, and 0.37 log(10) copies/mL, 95% CI: 0.00 to 0.74, P = 0.05, respectively]. There were no associations between viral load and other helminth species. There was some evidence that albendazole reduced viral load at 6 weeks after treatment (adjusted mean difference -0.17, 95% CI: -0.36 to 0.01, P = 0.07); however, this effect did not differ according to mother's hookworm infection status and had diminished at delivery (adjusted mean difference -0.11, 95% CI: -0.28 to 0.07, P = 0.23). There was no effect of praziquantel treatment on HIV load at any time point. CONCLUSIONS: Infection with some soil-transmitted helminth species is associated with increased HIV load in pregnancy. Treatment with albendazole causes a small decrease in HIV load; however, this may not represent a direct effect of worm removal.
BACKGROUND: To investigate the effect of helminth infections and their treatment during pregnancy on HIV load, we conducted a 2 × 2 factorial randomized controlled trial of albendazole versus placebo and praziquantel versus placebo in pregnant women in Entebbe, Uganda. METHODS: Two hundred sixty-four HIV-infected pregnant women from the Entebbe Mother and Baby Study (ISRCTN 32849447) were included in this analysis. Women were tested for helminth infections at enrollment, and mean HIV load was compared between infected and uninfected groups. The effect of anthelmintic treatment on HIV load was evaluated at 6 weeks after treatment and at delivery using linear regression and adjusting for enrollment viral load. RESULTS: Hookworm and Trichuris infections were associated with higher mean viral load at enrollment [adjusted mean difference 0.24 log10 copies/mL, 95% confidence interval (CI): 0.01 to 0.47, P = 0.03, and 0.37 log(10) copies/mL, 95% CI: 0.00 to 0.74, P = 0.05, respectively]. There were no associations between viral load and other helminth species. There was some evidence that albendazole reduced viral load at 6 weeks after treatment (adjusted mean difference -0.17, 95% CI: -0.36 to 0.01, P = 0.07); however, this effect did not differ according to mother's hookworm infection status and had diminished at delivery (adjusted mean difference -0.11, 95% CI: -0.28 to 0.07, P = 0.23). There was no effect of praziquantel treatment on HIV load at any time point. CONCLUSIONS: Infection with some soil-transmitted helminth species is associated with increased HIV load in pregnancy. Treatment with albendazole causes a small decrease in HIV load; however, this may not represent a direct effect of worm removal.
Authors: Per Kallestrup; Rutendo Zinyama; Exnevia Gomo; Anthony E Butterworth; Boniface Mudenge; Govert J van Dam; Jan Gerstoft; Christian Erikstrup; Henrik Ullum Journal: J Infect Dis Date: 2005-10-20 Impact factor: 5.226
Authors: Michael Brown; Moses Kizza; Christine Watera; Maria A Quigley; Samantha Rowland; Peter Hughes; James A G Whitworth; Alison M Elliott Journal: J Infect Dis Date: 2004-10-20 Impact factor: 5.226
Authors: Eyrun F Kjetland; Patricia D Ndhlovu; Exenevia Gomo; Takafira Mduluza; Nicholas Midzi; Lovemore Gwanzura; Peter R Mason; Leiv Sandvik; Henrik Friis; Svein Gunnar Gundersen Journal: AIDS Date: 2006-02-28 Impact factor: 4.177
Authors: Stefanie Knopp; Laura Rinaldi; I Simba Khamis; J Russell Stothard; David Rollinson; Maria P Maurelli; Peter Steinmann; Hanspeter Marti; Giuseppe Cringoli; Jürg Utzinger Journal: Trans R Soc Trop Med Hyg Date: 2009-01-24 Impact factor: 2.184
Authors: Emily L Webb; Patrice A Mawa; Juliet Ndibazza; Dennison Kizito; Alice Namatovu; Jacqueline Kyosiimire-Lugemwa; Bridget Nanteza; Margaret Nampijja; Lawrence Muhangi; Patrick W Woodburn; Hellen Akurut; Harriet Mpairwe; Miriam Akello; Nancy Lyadda; Joseph Bukusuba; Macklyn Kihembo; Moses Kizza; Robert Kizindo; Juliet Nabulime; Christine Ameke; Proscovia B Namujju; Robert Tweyongyere; Moses Muwanga; James A G Whitworth; Alison M Elliott Journal: Lancet Date: 2010-12-20 Impact factor: 79.321
Authors: Lawrence Muhangi; Patrick Woodburn; Mildred Omara; Nicholas Omoding; Dennison Kizito; Harriet Mpairwe; Juliet Nabulime; Christine Ameke; Linda A Morison; Alison M Elliott Journal: Trans R Soc Trop Med Hyg Date: 2007-06-06 Impact factor: 2.184
Authors: Sten H Vermund; Sarah J Fidler; Helen Ayles; Nulda Beyers; Richard J Hayes Journal: J Acquir Immune Defic Syndr Date: 2013-07 Impact factor: 3.731
Authors: Tara E Ness; Vedika Agrawal; Kathryn Bedard; Lara Ouellette; Timothy A Erickson; Peter Hotez; Jill E Weatherhead Journal: Am J Trop Med Hyg Date: 2020-11 Impact factor: 2.345
Authors: Dennison Kizito; Robert Tweyongyere; Alice Namatovu; Emily L Webb; Lawrence Muhangi; Swaib A Lule; Henry Bukenya; Stephen Cose; Alison M Elliott Journal: BMC Public Health Date: 2013-07-01 Impact factor: 3.295